By binding to serine 33 and serine 37 sites of p53, RITA prevents its interactions with MDM2 and MDM4 [25], leading to elevated levels of p53 protein, cell growth arrest, and cell apoptosis in tumor cells of a different origin in vitro and in vivo [26]. Here, MDM2 is linked to neoplasm.